Evidence map›Paper›PMID 29879736›Full record

ArticlePloS one2018

Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning.

Patrick Y Sips, Xu Shi, Gabriel Musso, Anjali K Nath, Yanbin Zhao, Jason Nielson, Jordan Morningstar, Amy E Kelly, Brittney Mikell, Eva Buys and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Redirecting Intermediary Metabolism to Counteract Cyanide Poisoning.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  3. Article
  4. Article
  5. A Missense Variant inBiomedicines · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Translational Toxicology in Zebrafish.Current opinion in toxicology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Patrick Y SipsDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.ORCID 0000-0001-9241-5980
Xu ShiDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America.
Gabriel MussoDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Anjali K NathDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America.
Yanbin ZhaoDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Jason NielsonBroad Institute, Cambridge, United States of America.
Jordan MorningstarDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America.
Amy E KellyDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Brittney MikellDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Eva BuysDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Vikhyat BebartaDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, United States of America.
Jared RutterDepartment of Biochemistry and Howard Hughes Medical Institute, University of Utah, Salt Lake City, United States of America.
V Jo DavissonDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue College of Pharmacy, West Lafayette, United States of America.
Sari MahonDepartment of Medicine, Beckman Laser Institute, University of California, Irvine, United States of America.
Matthew BrennerDepartment of Medicine, Beckman Laser Institute, University of California, Irvine, United States of America.
Gerry R BossDepartment of Medicine, University of California, San Diego, La Jolla, United States of America.
Randall T PetersonDivision of Cardiology, Department of Medicine, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, United States of America.
Robert E GersztenDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, United States of America.
Calum A MacRaeDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America.
Brigham and Women's Hospital · USBroad Institute · USBeth Israel Deaconess Medical Center · USUniversity of California, Irvine · USHoward Hughes Medical Institute · USPurdue University West Lafayette · USUniversity of California San Diego · USUniversity of Colorado Denver · US

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTOPHER P DUGGAN · 1994 to 2026
$31.6M
Validating promising drug candidates in mammalian models of CN poisoningU54NS079201 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI BOSS, GERRY R, PETERSON, RAYMOND J · 2012 to 2016
$12.6M
Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
Unbiased screens in zebrafish for new classes of cyanide countermeasureU01NS063563 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MACRAE, CALUM A. · 2008 to 2011
$1.1M
NIDDK NIH HHS P30 DK040561NIDDK NIH HHS T32 DK091317NINDS NIH HHS U01 NS063563NINDS NIH HHS U54 NS079201
6 · The paper itself

Abstract

Cyanide is a potent toxic agent, and the few available antidotes are not amenable to rapid deployment in mass exposures. As a result, there are ongoing efforts to exploit different animal models to identify novel countermeasures. We have created a pipeline that combines high-throughput screening in zebrafish with subsequent validation in two mammalian small animal models as well as a porcine large animal model. We found that zebrafish embryos in the first 3 days post fertilization (dpf) are highly resistant to cyanide, becoming progressively more sensitive thereafter. Unbiased analysis of gene expression in response to several hours of ultimately lethal doses of cyanide in both 1 and 7 dpf zebrafish revealed modest changes in iron-related proteins associated with the age-dependent cyanide resistance. Metabolomics measurements demonstrated significant age-dependent differences in energy metabolism during cyanide exposure which prompted us to test modulators of the tricarboxylic acid cycle and related metabolic processes as potential antidotes. In cyanide-sensitive 7 dpf larvae, we identified several such compounds that offer significant protection against cyanide toxicity. Modulators of the pyruvate dehydrogenase complex, as well as the small molecule sodium glyoxylate, consistently protected against cyanide toxicity in 7 dpf zebrafish larvae. Together, our results indicate that the resistance of zebrafish embryos to cyanide toxicity during early development is related to an altered regulation of cellular metabolism, which we propose may be exploited as a potential target for the development of novel antidotes against cyanide poisoning.

Indexed as

MetabolomicsAnimalsMetabolomePotassium CyanidePyruvate Dehydrogenase ComplexSwineZebrafishZebrafish ProteinsPotassium CyanidePyruvate Dehydrogenase ComplexZebrafish Proteins

Identifiers

PMID29879736
PMCPMC5991913
OpenAlexW2805368592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.